Identification of NS5B Resistance-Associated Mutations in Hepatitis C Virus Circulating in Treatment Naïve Vietnamese Patients

INTRODUCTION: Treatment of HCV infection with peginterferon and ribavirin results in a low sustained virologic response rate, but has a number of undesirable adverse effects. Direct-acting antivirals (DAAs) offer a high efficacy, low risk, and a short treatment time. However, the existence of resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thu Kim, Van Le, Duyet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994603/
https://www.ncbi.nlm.nih.gov/pubmed/35411152
http://dx.doi.org/10.2147/IDR.S353605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994603/
https://www.ncbi.nlm.nih.gov/pubmed/35411152
http://dx.doi.org/10.2147/IDR.S353605

Ejemplares similares